XASXSKN
Market cap2mUSD
Dec 23, Last price
0.00AUD
1D
0.00%
1Q
0.00%
IPO
-97.62%
Name
Skin Elements Ltd
Chart & Performance
Profile
Skin Elements Limited, a natural skin care company, develops, manufactures, distributes, and retails natural, organic, health, and wellness products in Australia. The company offers SuprCuvr, a disinfectant spray; Soléo Organics sunscreen; Papaya Activs for the treatment of skin conditions; and Elizabeth Jane for sensitive skin. Skin Elements Limited was incorporated in 2015 and is based in West Perth, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑12 | |
Income | ||||||||||
Revenues | 416 114.39% | 194 -86.22% | 1,408 387.75% | |||||||
Cost of revenue | 3,693 | 4,179 | 4,753 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (3,277) | (3,985) | (3,344) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (1,194) | (1,130) | (984) | |||||||
Tax Rate | ||||||||||
NOPAT | (2,083) | (2,855) | (2,360) | |||||||
Net income | (2,161) -81.07% | (11,416) 622.13% | (1,581) -48.04% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 200 | 1,512 | 1,817 | |||||||
BB yield | -11.96% | -43.26% | -16.50% | |||||||
Debt | ||||||||||
Debt current | 732 | 18 | 25 | |||||||
Long-term debt | 15 | 18 | 25 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 226 | |||||||||
Net debt | 632 | (323) | (1,035) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (279) | (1,836) | (1,498) | |||||||
CAPEX | (3) | |||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | 36 | 1,446 | 2,693 | |||||||
FCF | (918) | (1,791) | (2,663) | |||||||
Balance | ||||||||||
Cash | 115 | 358 | 748 | |||||||
Long term investments | 336 | |||||||||
Excess cash | 94 | 349 | 1,014 | |||||||
Stockholders' equity | (1,633) | 605 | 10,052 | |||||||
Invested Capital | 732 | 274 | 9,289 | |||||||
ROIC | ||||||||||
ROCE | 363.62% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 557,265 | 437,028 | 423,448 | |||||||
Price | 0.00 -62.50% | 0.01 -69.23% | 0.03 | |||||||
Market cap | 1,672 -52.18% | 3,496 -68.24% | 11,010 | |||||||
EV | 2,303 | 3,173 | 9,975 | |||||||
EBITDA | (3,270) | (3,579) | (2,938) | |||||||
EV/EBITDA | ||||||||||
Interest | 82 | 58 | 13 | |||||||
Interest/NOPBT |